Show results for
Refine by
Clinical Linked Data Equipment Supplied In Canada
10 equipment items found
Manufactured by:Flosonics Medical based inSudbury, ONTARIO (CANADA)
Point of care ultrasound assessments are vital to truly informed clinical decisions around fluid resuscitation and management. However, Doppler assessment with conventional bedside ultrasound is cumbersome and time consuming. Introducing the world's first wireless, wearable Doppler ultrasound. FloPatch provides clinicians with rapid, repeatable, and trusted hemodynamic assessments in seconds. ...
Manufactured by:THORASYS Thoracic Medical Systems Inc. based inMontreal, QUEBEC (CANADA)
The tremoflo C-100 Airwave Oscillometry System (AOS) measures lung function quickly and ...
Manufactured by:MolecuLight Inc. based inToronto, ONTARIO (CANADA)
Point-of-Care Wound Imaging Device for Detection of the Presence and Location of Elevated Bacterial Loads and Digital Wound ...
Manufactured by:Beckman Coulter, Inc. based inBrea, CALIFORNIA (USA)
The iChemVELOCITY sets the standard for automated urine chemistry analysis with the development of the ascorbic acid test pad to identify possible ascorbic acid interference with key chemistry assays, ensuring laboratories receive clinically relevant information. This urine chemistry instrument offers high throughput of up to 210 samples per hour and ease of use to maximize lab performance and ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCH-01 is a proprietary autologous cell therapy being developed to treat pattern baldness.* *This product is currently in clinical testing and not yet commercially available. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. Though several cell types are involved, dermal sheath cup cells, located at base of ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCS-01 is a proprietary autologous cell therapy being developed to rejuvenate aging or UV-damaged skin.* *This product is currently in clinical testing and not yet commercially available. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark has invested in and developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early stage diagnosis of lung ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCT-01 is a proprietary autologous cell therapy being developed to treat chronically damaged tendons. * *This product is currently in clinical testing and not yet commercially available. RCT-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide neuroprotection and to reduce intraocular pressure of the ...
Manufactured by:Hemostemix Inc. based inCalgary, ALBERTA (CANADA)
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The synergetic cell population, which can be collected from a simple blood draw, consists of progenitor and other supporting cells that are being developed for ...